Embed Size (px)
Citation preview
Supported by an educational grant from Merck & Co., Inc.
Jointly provided by Center for Independent Healthcare Education and Vemco MedEd
Please Join Us for a Saturday Morning CME/CPE Industry & Science Event at ASM Microbe 2018
Saturday, June 9, 20187:00 – 7:15 AM Registration & Breakfast7:15 – 8:30 AM Educational Program
Georgia World Congress Center285 Andrew Young Internal Blvd NWAtlanta, GA
Room: B211 -212
3322 US Highway 22 Suite 408Branchburg, NJ 08876
Register Online Today!www.vemcomeded.com (select “Register for Programs”)
FacultyKeith A. Rodvold PharmD, FCCP, FIDSA Professor of Pharmacy Practice and Medicine Colleges of Pharmacy and Medicine University of Illinois at Chicago Chicago, IL
Saturday, June 9, 20187:00 – 7:15 AM Registration and Breakfast
7:15 – 8:30 AM Educational ProgramGeorgia World Congress Center 285 Andrew Young Internal Blvd NW Atlanta, GA
Room: B211-212 Same Level as the Exhibit Hall Entrance
7:15 – 7:30 AM
7:30 – 8:20 AM
8:20 – 8:30 AM
Introduction: Challenges of High Priority Pathogens
Open Forum: Q&A
Understanding the Current MDR Gram-negative Landscape
Tools Targeting Priority Pathogens
REGISTRATIONThree easy ways to register:
1. Please go to www.vemcomeded.com and select “Register for Programs”
2. Email your name, affiliation, and mailing address to [email protected]
3. Use a QR Code Reader on your mobile device to register online by scanning the image.
Advanced registration is encouraged. There is no registration fee to attend this continuing education activity. This event is neither sponsored nor endorsed by the American Society of Microbiology.
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Center designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing
pharmacy education. Center has assigned 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credits for participating in this activity.
ACPE UAN: 0473-9999-18-005-L01-P Activity type: Knowledge-based For questions regarding accreditation, please contact [email protected]
DISCLOSURES OF CONFLICT OF INTERESTCenter for Independent Healthcare Education and Vemco MedEd require faculty, planners, and others who are in a position to control the content of continuing education activities to disclose to the audience any real or apparent conflict of
interest related to the activity. All identified conflicts of interest are reviewed and resolved to ensure fair balance, objectivity, and scientific rigor in all activities. The faculty is further required to disclose discussion of off-label uses in their presentations.
AMERICANS WITH DISABILITIES ACT
Vemco MedEd and Center for Independent Healthcare Education fully comply with the Americans With Disabilities Act. Please submit a written request at least 5 days prior to the meeting, and we will be glad to assist you with any special needs required to make this program accessible to you. Please email your request to [email protected].
Educational OverviewAntimicrobial-resistant Gram-negative bacteria continue to challenge clinicians. Several pathogens have been identified by the CDC and WHO that present serious healthcare threats, including ESBL-producing and carbapenem-resistant Enterobacteriaceae as well as multidrug-resistant P. aeruginosa. Addressing the issue of antimicrobial resistance requires a multifaceted approach that involves timely diagnosis and optimal use of traditional and newer antimicrobials that overcome various mechanisms of resistance. Healthcare providers involved in the management of serious bacterial infections must stay up-to-date on evidence-based approaches to optimize patient care. This program will review the current landscape of priority Gram-negative bacteria and provide guidance on utilizing rapid diagnostic approaches and newer antimicrobial agents aimed at improving clinical outcomes.
Target AudienceAddressing the challenges of priority Gram-negative bacteria requires an interprofessional approach that includes all healthcare providers involved in the prevention, diagnosis, and management of patients with or at risk for these infections. Therefore, this continuing medical education activity will target a variety of healthcare providers that include ID physicians, infection control specialists, hospital epidemiologists, hospitalists, clinical microbiologists, nurses, and clinical pharmacists.
Learning ObjectivesUpon completing this activity, participants will be able to:
• Discuss current epidemiological trends and resistance mechanisms of priority Gram-negative bacteria and their impact on clinical outcomes
• Assess the value of rapid diagnostic techniques in promoting pathogen-specific therapy
• Evaluate the potential role of new and emerging antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens
ACCREDITATION
